UA73972C2 - Galenical form with prolonged release of molsidomine - Google Patents

Galenical form with prolonged release of molsidomine Download PDF

Info

Publication number
UA73972C2
UA73972C2 UA2002086983A UA2002086983A UA73972C2 UA 73972 C2 UA73972 C2 UA 73972C2 UA 2002086983 A UA2002086983 A UA 2002086983A UA 2002086983 A UA2002086983 A UA 2002086983A UA 73972 C2 UA73972 C2 UA 73972C2
Authority
UA
Ukraine
Prior art keywords
molsidomine
sulfur
fuel
hours
hydrogen peroxide
Prior art date
Application number
UA2002086983A
Other languages
English (en)
Ukrainian (uk)
Original Assignee
Therabel Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therabel Pharmaceuticals Ltd filed Critical Therabel Pharmaceuticals Ltd
Publication of UA73972C2 publication Critical patent/UA73972C2/uk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
UA2002086983A 2000-02-24 2001-02-22 Galenical form with prolonged release of molsidomine UA73972C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0002307A FR2805462B1 (fr) 2000-02-24 2000-02-24 Nouvelle forme galenique orale a liberation prolongee de la molsidomine
PCT/EP2001/002055 WO2001062256A1 (fr) 2000-02-24 2001-02-22 Nouvelle forme galenique orale a liberation prolongee de la molsidomine

Publications (1)

Publication Number Publication Date
UA73972C2 true UA73972C2 (en) 2005-10-17

Family

ID=8847342

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2002086983A UA73972C2 (en) 2000-02-24 2001-02-22 Galenical form with prolonged release of molsidomine

Country Status (36)

Country Link
US (1) US7767227B2 (de)
EP (1) EP1265614B1 (de)
JP (1) JP4945043B2 (de)
KR (1) KR100814191B1 (de)
CN (1) CN100396284C (de)
AT (1) ATE296632T1 (de)
AU (2) AU2001240653B9 (de)
BE (1) BE1013487A3 (de)
BG (1) BG66111B1 (de)
BR (1) BRPI0108041B8 (de)
CA (1) CA2400886C (de)
CZ (1) CZ301993B6 (de)
DE (1) DE60111196T2 (de)
DZ (1) DZ3273A1 (de)
EE (1) EE05098B1 (de)
ES (1) ES2241803T3 (de)
FR (1) FR2805462B1 (de)
HK (1) HK1050138B (de)
HR (1) HRP20020692B1 (de)
HU (1) HU229799B1 (de)
IL (2) IL151205A0 (de)
IS (1) IS2446B (de)
MA (1) MA25576A1 (de)
MD (1) MD3119C2 (de)
MX (1) MXPA02008262A (de)
NO (1) NO329495B1 (de)
NZ (1) NZ520691A (de)
OA (1) OA12183A (de)
PL (1) PL201631B1 (de)
PT (1) PT1265614E (de)
RS (1) RS50291B (de)
RU (1) RU2263506C2 (de)
SK (1) SK286313B6 (de)
UA (1) UA73972C2 (de)
WO (1) WO2001062256A1 (de)
ZA (1) ZA200206042B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2805462B1 (fr) * 2000-02-24 2003-08-15 Therabel Res Nouvelle forme galenique orale a liberation prolongee de la molsidomine
US7803402B2 (en) * 2002-07-06 2010-09-28 Sanjeev Khandelwal Pharmaceutical preparations
FR2868314B1 (fr) * 2004-04-05 2008-10-24 Therabel Pharmaceuticals Ltd Nouvelle utilisation therapeutique de la molsidomine et de ses sels pharmaceutiquement acceptables
EP2468269A1 (de) 2010-11-26 2012-06-27 Universitätsklinikum Münster Nitridoxidspender bei der Behandlung von Nitridoxidmangel-induzierten Störungen der Hirnmikrozirkulation
BE1028879B1 (fr) 2020-12-11 2022-07-12 Europharmaceuticals Comprimé à libération prolongée de la molsidomine

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3522191A1 (de) * 1985-06-21 1987-01-15 Cassella Ag Photostabilisierung von sydnoniminen
CN1006522B (zh) * 1986-04-30 1990-01-24 田道制药有限公司 缓放性制剂的制备方法
HU210921B (en) * 1990-03-28 1995-09-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine formed with cyclodextrines and pharmaceutical compositions containing them
HU211648A9 (en) * 1990-03-28 1995-12-28 Chinoin Gyogyszer Es Vegyeszet Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same
DE4140192C2 (de) * 1991-12-05 1996-02-29 Alfatec Pharma Gmbh Sol-gesteuerte Thermokolloidmatrix auf Gelatinebasis für perorale Retardformen
DE59408793D1 (de) * 1993-05-11 1999-11-11 Hoechst Ag Galenische Zubereitungen von Molsidomin
WO1995001767A1 (en) * 1993-07-08 1995-01-19 Cygnus Therapeutic Systems Monolithic matrix transdermal delivery system
IT1266565B1 (it) * 1993-07-22 1997-01-09 Ct Lab Farm Srl Composizioni farmaceutiche a rilascio controllato a base di uno o piu' sali farmaceuticamente accettabili dell'acido gamma-idrossi-butirrico.
HU218280B (en) * 1994-04-26 2000-07-28 Cyclodextrin inclusion complexes containing sin-1a which are stable intheir solid state, process for their preparation and pharmaceutical compositions containing the comlexes
DE4443105C2 (de) * 1994-12-03 1997-03-13 Hoechst Ag Verfahren zur Herstellung Molsidomin-haltiger Tabletten
JPH09114680A (ja) * 1995-10-19 1997-05-02 Fuji Xerox Co Ltd シーケンス制御装置
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
PE57198A1 (es) * 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
JP2002522354A (ja) * 1997-09-19 2002-07-23 シャイア ラボラトリーズ,インコーポレイテッド 固溶体ビードレット
FR2775188B1 (fr) * 1998-02-23 2001-03-09 Lipha Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
FR2805462B1 (fr) * 2000-02-24 2003-08-15 Therabel Res Nouvelle forme galenique orale a liberation prolongee de la molsidomine

Also Published As

Publication number Publication date
JP2003523981A (ja) 2003-08-12
US20030045522A1 (en) 2003-03-06
KR20020081323A (ko) 2002-10-26
FR2805462A1 (fr) 2001-08-31
HRP20020692B1 (en) 2011-10-31
HUP0300607A2 (hu) 2003-08-28
PT1265614E (pt) 2005-10-31
ES2241803T3 (es) 2005-11-01
AU4065301A (en) 2001-09-03
EE200200472A (et) 2003-12-15
HK1050138B (zh) 2005-07-29
MXPA02008262A (es) 2004-04-05
HU229799B1 (en) 2014-07-28
HRP20020692A2 (en) 2004-02-29
EP1265614B1 (de) 2005-06-01
US7767227B2 (en) 2010-08-03
CA2400886A1 (fr) 2001-08-30
DZ3273A1 (fr) 2001-08-30
SK286313B6 (en) 2008-07-07
CA2400886C (fr) 2011-04-19
MD3119C2 (ro) 2007-04-30
NO20024043D0 (no) 2002-08-23
SK12202002A3 (sk) 2002-12-03
EE05098B1 (et) 2008-12-15
HK1050138A1 (en) 2003-06-13
WO2001062256A1 (fr) 2001-08-30
CN1419451A (zh) 2003-05-21
BG107027A (bg) 2003-04-30
OA12183A (fr) 2006-05-09
RS50291B (sr) 2009-09-08
IS6504A (is) 2002-08-14
ATE296632T1 (de) 2005-06-15
CN100396284C (zh) 2008-06-25
CZ301993B6 (cs) 2010-09-01
PL357550A1 (en) 2004-07-26
DE60111196D1 (de) 2005-07-07
HUP0300607A3 (en) 2006-02-28
BE1013487A3 (fr) 2002-02-05
BRPI0108041B8 (pt) 2021-05-25
BG66111B1 (bg) 2011-05-31
NO20024043L (no) 2002-08-23
MA25576A1 (fr) 2002-10-01
JP4945043B2 (ja) 2012-06-06
MD20020212A (en) 2002-12-31
FR2805462B1 (fr) 2003-08-15
KR100814191B1 (ko) 2008-03-17
AU2001240653B9 (en) 2005-10-27
IL151205A0 (en) 2003-04-10
IL151205A (en) 2011-01-31
ZA200206042B (en) 2003-07-29
DE60111196T2 (de) 2006-05-11
MD3119B2 (en) 2006-08-31
BR0108041A (pt) 2002-10-29
IS2446B (is) 2008-11-15
YU62202A (sh) 2006-01-16
EP1265614A1 (de) 2002-12-18
PL201631B1 (pl) 2009-04-30
BR0108041B1 (pt) 2013-06-18
NZ520691A (en) 2004-07-30
RU2263506C2 (ru) 2005-11-10
RU2002121503A (ru) 2004-03-20
NO329495B1 (no) 2010-11-01
AU2001240653B2 (en) 2005-05-26

Similar Documents

Publication Publication Date Title
UA74002C2 (en) A process for removal of sulphur compounds from the hydrocarbon fuel
AU2001279318A1 (en) Process for removing low amounts of organic sulfur from hydrocarbon fuels
US7276152B2 (en) Oxidative desulfurization and denitrogenation of petroleum oils
KR101897454B1 (ko) 황화나트륨을 분리 및 정제하는 방법
JP5475664B2 (ja) 苛性流から残留硫黄化合物を除去するプロセス
WO2016069450A2 (en) Process, method and system for removing heavy metals from fluids
WO2009099395A1 (en) Regeneration of solid adsorbent
UA73972C2 (en) Galenical form with prolonged release of molsidomine
CN101795971A (zh) 固体酸、其制造方法及将固体酸用作脱硫剂的烃油的脱硫方法
EP0611071A1 (de) Verfahren zum Regenerieren und gegebenfalls Carbonisieren von verbrauchten, Säure aktivierten Smektittonen
JP5655778B2 (ja) 有機溶媒の精製方法
WO2020256147A1 (ja) 精製ガスの製造方法及び精製ガス製造装置
FR2758554A1 (fr) Procede d'elimination d'inhibiteurs de polymerisation de melanges de monomeres a l'aide d'une alumine de forme optimisee
JP2007516817A (ja) ガス流からのh2s除去に有用な触媒、その調製方法、及びその使用
KR20240093858A (ko) 열분해 오일의 정제 방법
JPS6135128B2 (de)
EP1503974A1 (de) Verfahren zur entschwefelung eines kohlenwasserstoffgemisches.
WO1997035945A2 (en) Process for removal of organo-sulfur compounds from liquid hydrocarbons
Yang et al. Recovery of the dye intermediate DNDS from aqueous solution by adsorption onto resins
Sufnarski DHC QUALITYDJBPECTED 4
FR2635111A1 (fr) Procede d'adoucissement en continu de coupes petrolieres
JPH03145433A (ja) メチルナフタレン油から窒素化合物を分離する方法